John W. LaRocca
2019
In 2019, John W. LaRocca earned a total compensation of $2.5M as General Counsel and Assistant Secretary at Aerie Pharmaceuticals, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $136,848 |
|---|---|
| Option Awards | $1,454,807 |
| Salary | $430,000 |
| Stock Awards | $493,250 |
| Other | $9,454 |
| Total | $2,524,359 |
LaRocca received $1.5M in option awards, accounting for 58% of the total pay in 2019.
LaRocca also received $136.8K in non-equity incentive plan, $430K in salary, $493.3K in stock awards and $9.5K in other compensation.
Rankings
In 2019, John W. LaRocca's compensation ranked 4,817th out of 13,971 executives tracked by ExecPay. In other words, LaRocca earned more than 65.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,817 out of 13,971 | 66th |
Division Manufacturing | 1,795 out of 5,695 | 69th |
Major group Chemicals And Allied Products | 624 out of 2,194 | 72nd |
Industry group Drugs | 525 out of 1,880 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 116 out of 389 | 70th |
Source: SEC filing on April 24, 2020.
LaRocca's colleagues
We found five more compensation records of executives who worked with John W. LaRocca at Aerie Pharmaceuticals in 2019.
2019
Vicente Anido
Aerie Pharmaceuticals
Chief Executive Officer
2019
Thomas Mitro
Aerie Pharmaceuticals
Chief Operating Officer
2019
Richard Rubino
Aerie Pharmaceuticals
Chief Financial Officer
2019
David Hollander
Aerie Pharmaceuticals
Chief Research and Development Officer
2019
Casey Kopczynski
Aerie Pharmaceuticals
Chief Scientific Officer
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019